Harbour Trust & Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.89M Sell
35,017
-559
-2% -$130K 0.86% 33
2026
Q1
$8.7M Sell
35,576
-187
-0.5% -$43.6K 0.92% 32
2025
Q4
$7.4M Sell
35,763
-111
-0.3% -$21.9K 0.76% 40
2025
Q3
$6.65M Sell
35,874
-1,003
-3% -$172K 0.69% 43
2025
Q2
$5.63M Sell
36,877
-2,464
-6% -$379K 0.62% 45
2025
Q1
$6.52M Sell
39,341
-3,238
-8% -$507K 0.79% 42
2024
Q4
$6.16M Sell
42,579
-2,225
-5% -$345K 0.7% 46
2024
Q3
$7.26M Sell
44,804
-3,010
-6% -$480K 0.83% 38
2024
Q2
$6.99M Sell
47,814
-4,383
-8% -$652K 0.83% 35
2024
Q1
$8.26M Sell
52,197
-3,780
-7% -$602K 1.04% 28
2023
Q4
$8.77M Buy
+55,977
New +$8.58M 1.24% 24

Other funds holding JNJ

Harbour Trust & Investment Management's JNJ Position: Q2 2026 in Review

Harbour Trust & Investment Management reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q2 2026, selling an estimated $130K and leaving 35,017 shares worth $8.89M. The position accounts for 0.86% of the portfolio, ranked #33.

Harbour Trust & Investment Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 2,377 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Harbour Trust & Investment Management held 35,017 shares of Johnson & Johnson worth $8.89M as of Q2 2026.
  • Harbour Trust & Investment Management sold 559 Johnson & Johnson shares in Q2 2026, an estimated $130K.
  • Johnson & Johnson made up 0.86% of Harbour Trust & Investment Management's portfolio in Q2 2026, its #33 holding.
  • Harbour Trust & Investment Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 2,377 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Harbour Trust & Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.